Digital Literacy and Emotional Intelligence and Professional Burnout Among Doctors
Launched by LIMITED LIABILITY COMPANY "DOCSTARCLUB" · Mar 31, 2024
Trial Information
Current as of July 05, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how improving digital skills and emotional intelligence can help doctors manage stress and avoid burnout. As healthcare becomes more digital, many doctors find it challenging to keep up with new technologies while also dealing with their emotional well-being. This research aims to show that by building emotional resilience—essentially, the ability to understand and manage their feelings—doctors can better adapt to using digital tools in their work. The goal is to create a more balanced and effective healthcare environment for both doctors and their patients.
To participate in this trial, doctors need to have a higher medical education and currently work in a medical setting. The study is open to all genders and is looking for participants aged 65 to 74 and older. Those who join can expect to engage in training that enhances their emotional intelligence and digital skills, ultimately fostering a healthier work-life balance and improving their interactions with patients and colleagues. This research is important because it not only aims to reduce burnout but also supports doctors in becoming more comfortable and efficient with the technology that is now a big part of healthcare.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • respondent has higher medical education
- • he is an employee of the any medical department at this moment
- Exclusion Criteria:
- • There is no higher medical education
- • Does not work in medicine at this moment
About Limited Liability Company "Docstarclub"
Docstarclub, a limited liability company, is dedicated to advancing medical research and improving patient outcomes through innovative clinical trials. With a focus on ethical practices and regulatory compliance, Docstarclub collaborates with healthcare professionals and research institutions to develop and test cutting-edge therapies in various therapeutic areas. Committed to fostering transparency and integrity, the company aims to contribute significantly to the medical community by facilitating access to life-changing treatments and enhancing the understanding of disease management.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Moscow, , Russian Federation
Patients applied
Trial Officials
Anna N. Korobeynikova
Principal Investigator
Limited Liability Company "Docstarclub"
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported